Show simple item record

FieldValueLanguage
dc.contributor.authorFaasse, Kate
dc.contributor.authorHuynh, Anna
dc.contributor.authorPearson, Sarah
dc.contributor.authorGeers, Andrew L
dc.contributor.authorHelfer, Suzanne
dc.contributor.authorColagiuri, Ben
dc.date.accessioned2020-02-11
dc.date.available2020-02-11
dc.date.issued2018-09-10
dc.identifier.citationFaasse, K., Huynh, A., Pearson, S., Geers, A. L., Helfer, S. G., & Colagiuri, B. (2019). The influence of side effect information framing on nocebo effects. Annals of Behavioral Medicine, 53(7), 621-629.en_AU
dc.identifier.urihttps://hdl.handle.net/2123/21828
dc.description.abstractBackground: One contributing factor to the development of nocebo effects is information provided about possible side effects. However, non-disclosure of information can be problematic. Purpose: We assessed whether positively framed side effect information (highlighting likelihood of not experiencing side effects) can reduce nocebo effects compared to negatively framed information (highlighting likelihood of experiencing side effects). Method: One-hundred-and-twelve participants took part in research ostensibly assessing the influence of benzodiazepines (actually sham capsules) on anxiety. Participants were randomized to receive a sham capsule with positively or negatively framed information about four side effects, or a no treatment control condition. Side effect expectations were assessed after information provision. Framed side effects and other unmentioned symptoms were assessed during the session and 24-hour follow-up. Results: Nocebo effects occurred in symptoms presented as side effects (regardless of framing) during the study session and follow-up (ps < .003). At follow-up, there was also a nocebo effect in other unmentioned symptoms (p = .018). Positive framing reduced side effect symptoms compared with negative framing during the study session (p = .037), but this effect was no longer present at follow-up (p = .53). Side effect expectations did not differ between the framing conditions (p = .14). Conclusions: Positive framing reduced side effects short-term, but not at follow-up. Expectations did not differ between negative and positive framing. Nocebo effects appeared to generalise to other unmentioned symptoms over a 24-hour period. Further research is needed to determine whether the initial impact of positive framing can be maintained over time.en_AU
dc.description.sponsorshipAustralian Research Councilen_AU
dc.publisherOxford Academicen_AU
dc.relationDE160100864, DP180102061en_AU
dc.subjectNoceboen_AU
dc.subjectPlaceboen_AU
dc.subjectFramingen_AU
dc.subjectExpectationsen_AU
dc.subjectSide effectsen_AU
dc.titleThe Influence of Side Effect Information Framing on Nocebo Effectsen_AU
dc.typeArticleen_AU
dc.subject.asrc170199en_AU
dc.identifier.doi10.1093/abm/kay071
dc.type.pubtypePost-printen_AU


Show simple item record

Associated file/s

Associated collections

Show simple item record

There are no previous versions of the item available.